Matthew Strobeck - May 31, 2022 Form 4 Insider Report for Accelerate Diagnostics, Inc (AXDX)

Role
Director
Signature
/s/ Steven Reichling, attorney-in-fact
Stock symbol
AXDX
Transactions as of
May 31, 2022
Transactions value $
$0
Form type
4
Date filed
6/2/2022, 04:22 PM
Previous filing
Jun 1, 2022
Next filing
Jun 8, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AXDX Employee Restricted Stock Units Award $0 +75.9K $0.00 75.9K May 31, 2022 Common Stock 75.9K Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.
F2 The restricted stock units vest in full on May 31, 2023. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. Pursuant to the issuer's Director Equity Deferral Program, the reporting person has elected to defer receipt of the shares of common stock upon vesting of the restricted stock units to such time that is within 30 days following his departure from the issuer's board of directors.
F3 Not applicable.